Type: Press Release

Columbia, Maryland, April 4, 2018 – Welldoc®, a leading digital therapeutics company, announced today that its executives and digital health, diabetes and healthcare industry thought leaders will speak and/or participate in panel discussions at prominent diabetes and healthcare conferences this Spring. The list of events is as follows: Johns Hopkins Clinical Continuing Education Series April…

Columbia, MD, April 3, 2018​ – Today, Welldoc ® announced a pilot program in the Providence Health & Services Oregon/SW Washington Region to examine the use of Welldoc’s BlueStar®, an FDA-cleared, proven digital therapeutic for individuals with type 2 diabetes. The Providence Health & Services pilot program will include individuals living with type 2 diabetes…

Columbia, Maryland, March 22, 2018 – WellDoc®, a leading digital therapeutic company, announces today the formation of its scientific advisory team whose expertise spans cardiology, health behavior, endocrinology, primary care and pharmacy-based diabetes education and care. Richard Katz, MD, Janet Duni, RN, BSN, MPA, CCM, Pablo Mora, MD, Nancy D’Hondt, RPh, CDE, FAADE, Edwin Fisher,…

Program Available on U.S.-Based Samsung Galaxy Devices Designed to Support a Healthy Lifestyle for Individuals Living with Type 2 Diabetes MOUNTAIN VIEW, CALIFORNIA and COLUMBIA, MARYLAND – March 6, 2018 – Samsung Electronics America, Inc. and WellDoc®, a leading digital therapeutic company, announced today that Samsung Health users now have access to a new consumer…

Jill Berger, Kristine Seymour and Jason Rose to Serve as WellDoc Advisors Columbia, Maryland, February 28, 2018 – WellDoc®, a leading digital therapeutic company, announced today that it has expanded its advisory team with experts in employer benefits, payer relations and healthcare information technology (IT). Jill Berger, Kristine Seymour and Jason Rose now serve as…

Columbia, Maryland, January 18, 2018 – WellDoc®, a leading digital therapeutic company, announced  today that John L. Brooks, III, a recognized life-sciences executive with more than 40 years of experience, will join the company’s team as a strategic advisor. “We’re pleased that John has chosen to work with us as an advisor,” said WellDoc President…

Solera Health will integrate the BlueStar® Digital Therapeutic, a diabetes management solution, into its national network of Diabetes Prevention Program providers Phoenix, AZ, and Columbia, MD, January 17, 2018 – ​Solera Health, an integrated benefit network, and WellDoc®, a leading digital therapeutic company, announced today that WellDoc’s BlueStar® digital therapeutic will join the Solera network…

Cambridge, MA, and Columbia, MD, January 9, 2018 – Voluntis and WellDoc®, two of the industry’s leading digital therapeutics companies, announced today a commercial agreement aimed at combining Voluntis’ insulin titration technology with WellDoc’s extensive digital coaching platform to create a holistic digital diabetes management solution for patients, providers, health systems and health plans. Voluntis…

Columbia, Maryland, January 8, 2018 – WellDoc®, a leading digital health company, announced that two executives will present at key digital health conferences this week. President and CEO Kevin McRaith will give a corporate overview at the 2018 Digital Medicine and Medtech Showcase at Parc 55 in San Francisco on January 9, at 11:30 a.m….

Columbia, Maryland, January 4, 2018 – WellDoc®, a leading digital health company, announced today that its clinically proven hemoglobin A1C reductions for users of its BlueStar® digital therapeutic with type 2 diabetes can translate into significant healthcare cost savings. Truven Health Analytics®, part of the IBM Watson Health™ business, conducted an analysis for WellDoc using…